Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inflamed phenotype of splenic marginal zone B-cell lymphomas with expression of PD-L1 by intratumoral monocytes/macrophages and dendritic cells.

Literature DB >> 30967638

Inflamed phenotype of splenic marginal zone B-cell lymphomas with expression of PD-L1 by intratumoral monocytes/macrophages and dendritic cells.

Christelle Vincent-Fabert¹, Isabelle Soubeyran², Valérie Velasco², Marie Parrens³, Robin Jeannet¹, Emilie Lereclus¹, Nathalie Gachard¹, Jean Feuillard¹, Nathalie Faumont⁴.

Abstract

Entities: Disease Gene

Mesh：

Substances：
B7-H1 Antigen

Year: 2019 PMID： 30967638 PMCID： PMC6804598 DOI： 10.1038/s41423-019-0228-y

Source DB: PubMed Journal: Cell Mol Immunol ISSN： 1672-7681 Impact factor: 11.530

× No keyword cloud information.

15 in total

1. Among 157 marginal zone lymphomas, DBA.44(CD76) expression is restricted to tumour cells infiltrating the red pulp of the spleen with a diffuse architectural pattern.

Authors: Barbara Petit; Marie Parrens; Isabelle Soubeyran; Valérie Costes-Martineau; Nathalie Gachard; Mélanie Boulin; Camille Laurent; Abdelghafour Marfak; François Labrousse; Dominique Bordessoule; Jean Feuillard
Journal: Histopathology Date: 2009-04 Impact factor: 5.087

2. Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes.

Authors: Poonam K Panjwani; Vivek Charu; Monique DeLisser; Hernan Molina-Kirsch; Yasodha Natkunam; Shuchun Zhao
Journal: Hum Pathol Date: 2017-11-06 Impact factor: 3.466

3. Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment.

Authors: Helena Harlin; Yuru Meng; Amy C Peterson; Yuanyuan Zha; Maria Tretiakova; Craig Slingluff; Mark McKee; Thomas F Gajewski
Journal: Cancer Res Date: 2009-03-17 Impact factor: 12.701

4. Immunohistochemical and immunoelectron microscopic localization of S-100 protein in the interdigitating reticulum cells of the human lymph node.

Authors: K Takahashi; H Yamaguchi; J Ishizeki; T Nakajima; Y Nakazato
Journal: Virchows Arch B Cell Pathol Incl Mol Pathol Date: 1981

5. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.

Authors: Salvatore Perrone; Gianna Maria D'Elia; Giorgia Annechini; Antonietta Ferretti; Maria Elena Tosti; Robin Foà; Alessandro Pulsoni
Journal: Leuk Res Date: 2016-03-22 Impact factor: 3.156

Inflamed phenotype of splenic marginal zone B-cell lymphomas with expression of PD-L1 by intratumoral monocytes/macrophages and dendritic cells.

1. Among 157 marginal zone lymphomas, DBA.44(CD76) expression is restricted to tumour cells infiltrating the red pulp of the spleen with a diffuse architectural pattern.

2. Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes.

3. Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment.

4. Immunohistochemical and immunoelectron microscopic localization of S-100 protein in the interdigitating reticulum cells of the human lymph node.

5. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.

6. Macrophages in human tumours: an immunohistochemical study.

Review 7. Harmonization of PD-L1 testing in oncology: a Canadian pathology perspective.

Review 8. PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics.

Review 9. PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.

10. Several immune escape patterns in non-Hodgkin's lymphomas.

Review 1. Role and Mechanisms of Tumor-Associated Macrophages in Hematological Malignancies.

2. A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade.